Filing Flows

Filing Flows › Immucell (ICCC) › Next earnings date

Immucell (ICCC) earnings on Nov 12, 2026: what to expect

Immucell (ICCC) is expected to report earnings on Nov 12, 2026, in 4 days, for the quarter ending Mar 31, 2021. It beat the EPS estimate in 67% of the quarters on record; Filing Flows' model gives it a 64% chance of beating next time.

Report dateNov 12, 2026
Days to go4
Beat rate67%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Immucell: revenue lines, growth year over year, Q2 2026Immucell: revenue lines, growth year over year, Q2 2026Revenue+12%

The last report

Immucell reported revenue of $7.2M for the second quarter 2026 (+12% Y/Y), net earnings $1.8M. How it makes money → · Every quarter →

Immucell: EPS against the estimate, last 3 reportsImmucell: EPS against the estimate, last 3 reportsEstimateReported−$0.10−$0.11Aug 20−$0.08−$0.04Nov 20−$0.04$0.03Feb 21
Latest (Feb 21): Estimate −$0.04, Reported $0.03.

Immucell's latest quarter

Immucell, Q2 2026: revenue $7.2M (+12% year over year), operating margin 26.9%, net earnings $1.8M, operating cash flow $3.0M. The chart follows the revenue to costs, profit and cash.

Questions

When does ICCC report earnings?

Immucell is expected to report on Nov 12, 2026.

Does Immucell usually beat earnings?

It beat the consensus EPS estimate in 67% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.